Neuren Pharmaceuticals | NEU - Debt

Stock Price
13.44
Daily Change
0.73 5.74%
Monthly
-22.89%
Yearly
-5.35%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD0 in Debt for its fiscal semester ending in December of 2024.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 44.59M 1.4M Jun/2025
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Genetic Signatures AUD 791K 223K Jun/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
Medical Developments International AUD 1.99M 152K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organon & Co USD 8.83B 68M Sep/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Starpharma Holdings AUD 2.4M 73K Jun/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Telix Pharmaceuticals AUD 418.25M 163.2M Jun/2025
Viatris USD 14.41B 25.6M Dec/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025